American Journal of Epidemiology Advance Access originally published online on December 21, 2007
American Journal of Epidemiology 2008 167(6):701-710; doi:10.1093/aje/kwm342
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL CONTRIBUTIONS |
Maternal Thyroid Autoantibodies during the Third Trimester and Hearing Deficits in Children: An Epidemiologic Assessment
1 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
2 Department of Microbiology and Molecular Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
3 Center for Autoimmune Disease Research, Johns Hopkins Medical Institutions, Baltimore, MD
4 Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
5 Department of Audiology, Kennedy Krieger Institute, Johns Hopkins Medical Institutions, Baltimore, MD
6 Department of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD
7 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
8 Stanley Division of Developmental Neurovirology, Johns Hopkins Medical Institutions, Baltimore, MD
Correspondence to Dr. Ellen E. Wasserman, 1750 East Fairmount Avenue, #1034, Baltimore, MD 21231 (e-mail: ewasser1{at}jhmi.edu).
Received for publication April 24, 2007. Accepted for publication November 16, 2007.
Elevated maternal thyroid autoantibodies during pregnancy are linked to infertility, miscarriage, and neurodevelopmental deficits such as in cognitive function. It has not been established whether autoantibodies to thyroid peroxidase are associated with sensorineural hearing loss (SNHL). The authors tested stored third-trimester maternal serum specimens of 1,736 children for thyroid peroxidase autoantibodies (TPOaAb) by using an enzyme-linked immunosorbent assay technique. The children participated at the Baltimore, Maryland, site of the Collaborative Perinatal Project, which enrolled pregnant women in 1959–1965. An audiology examination was administered to the children at 8 years of age and was used to identify cases of SNHL. Compared with 4.3% of the other children, 22.7% of the children whose mothers had elevated TPOaAb (
62.5 IU/ml) had SNHL. The difference was significant after controlling for maternal race, age, and hypothyroidism (exact prevalence odds ratio = 7.5, 95% confidence interval: 2.4, 23.3). When a lower cutoff of TPOaAb 31.25 IU/ml was used, there continued to be an association with SNHL (exact prevalence odds ratio = 5.7, 95% confidence interval: 2.1, 15.6). The direction and magnitude of the association were similar when an alternative case definition of SNHL was used. These data suggest that antenatal exposure to maternal TPOaAb during the third trimester of pregnancy is associated with impaired auditory development.
abnormalities; autoimmunity; child development; hearing; pregnancy
Abbreviations: CPP, Collaborative Perinatal Project; SNHL, sensorineural hearing loss; TPOaAb, thyroid peroxidase autoantibodies